Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorOils/Energy
Phone31-20-420-3191
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$700.84 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date4/24/2019 (Estimated)
OptionableOptionable
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories declared a quarterly dividend on Wednesday, January 16th. Stockholders of record on Friday, January 25th will be given a dividend of $0.55 per share on Friday, February 15th. This represents a $2.20 annualized dividend and a dividend yield of 3.10%. The ex-dividend date of this dividend is Thursday, January 24th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Wednesday, January, 30th. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.49 by $0.01. The oil and gas company earned $173.20 million during the quarter, compared to analyst estimates of $173.90 million. Core Laboratories had a net margin of 11.35% and a return on equity of 63.86%. Core Laboratories's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.58 earnings per share. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories updated its first quarter earnings guidance on Wednesday, January, 30th. The company provided EPS guidance of $0.42-0.45 for the period, compared to the Thomson Reuters consensus estimate of $0.42. The company issued revenue guidance of $164-168 million, compared to the consensus revenue estimate of $165.34 million.Core Laboratories also updated its Q1 2019 guidance to $0.42-0.45 EPS.
What price target have analysts set for CLB?
15 Wall Street analysts have issued 12 month target prices for Core Laboratories' stock. Their predictions range from $66.00 to $130.00. On average, they anticipate Core Laboratories' share price to reach $90.90 in the next twelve months. This suggests a possible upside of 28.1% from the stock's current price. View Analyst Price Targets for Core Laboratories.
What is the consensus analysts' recommendation for Core Laboratories?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.
Has Core Laboratories been receiving favorable news coverage?
News headlines about CLB stock have been trending somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Core Laboratories earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned press coverage about the oil and gas company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Braskem (BAK), Noble Energy (NBL), Cabot Oil & Gas (COG), Cenovus Energy (CVE), TechnipFMC (FTI), Enel Americas (ENIA), National-Oilwell Varco (NOV), Targa Resources (TRGP), KUNLUN ENERGY C/ADR (KLYCY), HollyFrontier (HFC), Showa Shell Sekiyu KK (SWSKF), Andeavor Logistics (ANDX), Ultrapar Participacoes (UGP), Energen (EGN) and Western Gas Equity Partners (WGP).
What other stocks do shareholders of Core Laboratories own?
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
- Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 58)
- Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
- Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
- Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (11.11%), BlackRock Inc. (7.41%), Massachusetts Financial Services Co. MA (5.90%), Kayne Anderson Rudnick Investment Management LLC (3.13%), Epoch Investment Partners Inc. (2.64%) and Millennium Management LLC (1.80%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.
Which major investors are selling Core Laboratories stock?
CLB stock was sold by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Kayne Anderson Rudnick Investment Management LLC, Wedgewood Partners Inc., Epoch Investment Partners Inc., Bank of America Corp DE, Macquarie Group Ltd., Raymond James & Associates and Prudential Financial Inc.. View Insider Buying and Selling for Core Laboratories.
Which major investors are buying Core Laboratories stock?
CLB stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Millennium Management LLC, Norges Bank, Van ECK Associates Corp, Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Mairs & Power INC and UBS Oconnor LLC. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $70.94.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $3.14 billion and generates $700.84 million in revenue each year. Core Laboratories employs 4,700 workers across the globe.
What is Core Laboratories' official website?
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (NYSE CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
